Literature DB >> 11260384

No evidence for AT2R gene derangement in human urinary tract anomalies.

M Hiraoka1, T Taniguchi, H Nakai, M Kino, Y Okada, A Tanizawa, H Tsukahara, Y Ohshima, I Muramatsu, M Mayumi.   

Abstract

BACKGROUND: It has been recently found that mice, especially males, with a disrupted angiotensin type 2 receptor (AT2R) gene, which is located on the X-chromosome, often have a range of congenital anomalies of the kidney and urinary tract (CAKUT), including renal hypoplasia, and that Caucasian male patients with ureteropelvic junction stenosis (UPJ) and multicystic dysplastic kidneys frequently have A-G transition in intron 1 of the AT2R gene. We have previously found that renal hypoplasia is remarkably predominant in Japanese boys.
METHODS: We investigated sex ratios for the frequency of each CAKUT. The frequency of the A-G transition between the controls and 66 Japanese boys with CAKUT were compared. There was renal hypoplasia in 16, UPJ in 17, vesicoureteral in 20, and other anomalies in 13. We also investigated whether any mutations in AT2R genes were detectable in patients with renal hypoplasia.
RESULTS: In contrast to mice with a disruption of the AT2R gene, the male-to-female ratios in human patients proved to be considerably variable: 16 for renal hypoplasia, 2.1 for UPJ, 0.8 for vesicoureteral, and 1.2 for others. The frequency of the A-G transition was not different between the control population and the patients with CAKUT [31 of 102 (30%) vs. 23 of 66 (35%), respectively]. A sequencing study disclosed no mutations in nine boys with renal hypoplasia.
CONCLUSIONS: These findings indicate that the AT2R gene may not play a major role in the development of renal hypoplasia and other CAKUT in humans, at least in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260384     DOI: 10.1046/j.1523-1755.2001.0590041244.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  No evidence for angiotensin type 2 receptor gene polymorphism in intron 1 in patients with coarctation of the aorta and Ullrich-Turner syndrome.

Authors:  E Struwe; K Krammer; J Dötsch; M Metzler; H G Dörr; R Cesnjevar; W Rascher; A Koch
Journal:  Pediatr Cardiol       Date:  2006-08-30       Impact factor: 1.655

Review 2.  [Prognostic markers for congenital hydronephroses].

Authors:  S Conrad
Journal:  Urologe A       Date:  2007-02       Impact factor: 0.639

3.  Implication of genetic variations in congenital obstructive nephropathy.

Authors:  Hyewon Hahn; So-Eun Ku; Kun-Suk Kim; Young-Seo Park; Chong-Hyun Yoon; Hae-Il Cheong
Journal:  Pediatr Nephrol       Date:  2005-08-25       Impact factor: 3.714

4.  Mutation screening of BMP4 and Id2 genes in Chinese patients with congenital ureteropelvic junction obstruction.

Authors:  Jun Li He; Jun Hong Liu; Feng Liu; Ping Tan; Tao Lin; Xu Liang Li
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

Review 5.  Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy.

Authors:  Robert L Chevalier; Barbara A Thornhill; Michael S Forbes; Susan C Kiley
Journal:  Pediatr Nephrol       Date:  2009-10-21       Impact factor: 3.714

6.  Congenital anomalies of the kidney and urinary tract: a genetic disorder?

Authors:  Ihor V Yosypiv
Journal:  Int J Nephrol       Date:  2012-05-20

Review 7.  LOX-1 and angiotensin receptors, and their interplay.

Authors:  Xianwei Wang; M Ian Phillips; Jawahar L Mehta
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

Review 8.  The term CAKUT has outlived its usefulness: the case for the prosecution.

Authors:  Adrian S Woolf
Journal:  Pediatr Nephrol       Date:  2022-05-16       Impact factor: 3.651

9.  Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin A nephropathy in Korean patients.

Authors:  Hyung Jin Yoon; Ho Jun Chin; Ki Young Na; Dong-Wan Chae; Suhnggwon Kim; Un Sil Jeon; Woo Kyung Chung; Hyun Hee Lee; Jaeseok Yang; Sejoong Kim; Young-Joo Kwon; Hyun Chul Kim; Sung Bae Park; Hye Young Kim; Tae Woo Lee
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.